Table of Contents

company-logo

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Aerovate Therapeutics Dividend Announcement

• Aerovate Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Aerovate Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Aerovate Therapeutics Dividend History

Aerovate Therapeutics Dividend Yield

Aerovate Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Aerovate Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Aerovate Therapeutics Financial Ratios

P/E ratio-0.86
PEG ratio0.02
P/B ratio0.80
ROE-83.65%
Payout ratio0.00%
Current ratio6.51
Quick ratio6.51
Cash Ratio1.83

Aerovate Therapeutics Dividend FAQ

Does Aerovate Therapeutics stock pay dividends?
Aerovate Therapeutics does not currently pay dividends to its shareholders.
Has Aerovate Therapeutics ever paid a dividend?
No, Aerovate Therapeutics has no a history of paying dividends to its shareholders. Aerovate Therapeutics is not known for its dividend payments.
Why doesn't Aerovate Therapeutics pay dividends?
There are several potential reasons why Aerovate Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Aerovate Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Aerovate Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Aerovate Therapeutics a dividend aristocrat?
Aerovate Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Aerovate Therapeutics a dividend king?
Aerovate Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Aerovate Therapeutics a dividend stock?
No, Aerovate Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Aerovate Therapeutics stocks?
To buy Aerovate Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Aerovate Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.